Total investments received (USD): 44.91m
Round value (USD): 15m
Round investors:
Eli Lilly and Company
Company: MiNA Therapeutics
Industry:
Biotech
Health services






Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Portugal
Spain